A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

This study has been completed.

Sponsor:

Intarcia Therapeutics

ClinicalTrials.gov Identifier:

NCT01455896

First Posted: October 20, 2011

Last Update Posted: January 27, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.